Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 9242

Summit, NJ 07902

Study Summary:

This study will investigate the ability of ST101 to improve memory in people with Alzheimer's disease who currently receive 10 mg Aricept® (donepezil) per day. This study also will examine the safety and tolerability of the drug. This study is evaluating 3 different dose levels of ST101 and placebo. Patients will have a 1 in 4 chance of getting placebo. All eligible subjects will be provided with bottles of 10 mg Aricept (donepezil) during the study drug administration part of the study.

Qualified Participants Must:

• Be taking 10 mg of Aricept/Donepezil for at least 90 days
• Have a caregiver who interacts with the patient daily and is willing to participate in the study

Qualified Participants May Receive:

Eligible participants will be provided no cost access to study related medications, monitoring and evaluations by experienced specialists, who have over 20 years of Alzheimer’s research and treatment experience.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.